Current Edition

Upcoming Events

Advertisement

Betting on the Bug: The Microbiome’s Impact on Drug Efficacy
Volume 2 Issue 3

Betting on the Bug: The Microbiome’s Impact on Drug Efficacy

As explored in part one of this article series, it is well documented that the microbiome of research models can have a profound effect on experimental reproducibilit...
Continue Reading →
Turning Negatives into Positives: How Dissenters can Help Improve RIM Transformation Success
Volume 2 Issue 3

Turning Negatives into Positives: How Dissenters can Help Improve RIM Transformation Success

Ultimately, it is people that determine whether a major transformation project will deliver the hoped-for results, and it is unrealistic to expect everyone to get beh...
Continue Reading →
Multi-modal Positron Emission Tomography (PET) Advances Preclinical Pharmaceutical Research
Volume 2 Issue 3

Multi-modal Positron Emission Tomography (PET) Advances Preclinical Pharmaceutical Research

Nuclear molecular imaging is a popular research tool across multiple preclinical applications including oncology, neurology, and cardiology. Todd Sasser at Bruker Bio...
Continue Reading →
Biology 3.0: The Single-Cell (R)evolution
Volume 2 Issue 3

Biology 3.0: The Single-Cell (R)evolution

Understanding how cells make choices is one of the great challenges in biology. Whether it is the first cell divisions of embryonic development or activation in respo...
Continue Reading →
CRISPR Advances Can Accelerate Biopharmaceutical Drug Discovery and Development
Volume 2 Issue 3

CRISPR Advances Can Accelerate Biopharmaceutical Drug Discovery and Development

For several years, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has been making waves in the scientific community. Its ability to pre...
Continue Reading →
Becoming a Champion Go Player
Volume 2 Issue 3

Becoming a Champion Go Player

Although antibodies, at the time of writing, still dominate the clinic, there is a definite shift in the drug development pipeline towards more “complex”, next-genera...
Continue Reading →
Why We Need New Diagnostics for the Zika Virus
Volume 2 Issue 3

Why We Need New Diagnostics for the Zika Virus

While Zika is no longer in the public eye, it hasn’t vanished. Recent outbreaks across Asia and Africa are reminders that Zika is alive and well, and with no effectiv...
Continue Reading →
Virus-like particles: Versatile platforms
Volume 2 Issue 3

Virus-like particles: Versatile platforms

Vaccination represents, together with the supply of fresh water, the most efficient tool to prevent infectious diseases in human. Vaccines` power is undeniable, ever ...
Continue Reading →
Rapid, Automated At-line Antibody Titer Measurements Advance Biopharmaceutical Production
Volume 2 Issue 3

Rapid, Automated At-line Antibody Titer Measurements Advance Biopharmaceutical Production

Biotherapeutic production relies on robust cell lines with reproducible growth, titre and quality, so determining the titre of biopharmaceuticals at multiple points d...
Continue Reading →
The Digital Content Revolution of the Pharmaceutical Industry
Volume 2 Issue 3

The Digital Content Revolution of the Pharmaceutical Industry

The digital transformation of the pharmaceutical industry has been slow and is far from complete. This unique transformation started with basic video content in the e...
Continue Reading →